Dolby Family Ventures
San Francisco, California, United StatesFounded 2014
Dolby Family Ventures is a single-family office venture firm managing the Dolby family's wealth, investing proprietary capital into early-stage science and engineering startups tackling complex technical challenges. It is not affiliated with Dolby Laboratories, Inc.
Deal activity decreased year-over-year (4 deals in the last 12 months vs 6 prior). Their most common stage is series-a (42% of deals). Average disclosed round size is $26.1M (across 94 rounds with reported amounts).
Portfolio
77
Fund Size
—
Top Stage
Series A
Last 12 Mo
4
Team
David Dolby
CEO
DT
Douglas Talbert
Associate
SK
Sourav Kole, PhD
Healthcare Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
100 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Transition Metal Solutions | Seed | $6M | Jan 2026 |
 Transition Metal Solutions | Seed | $6M | Jan 2026 |
 Transition Metal Solutions | Seed | $6M | Jan 2026 |
 NeuroBionics | Seed | $10M | Dec 2025 |
 Sensorium Therapeutics | Series A | $25M | Aug 2025 |
 Sensorium | Series A | $25M | Aug 2025 |
 Salvia BioElectronics | Series B | $60M | May 2025 |
 Therini Bio | Series A | $39M | May 2025 |
 Potato | Seed | $4.5M | Apr 2025 |
 Potato | Seed | $4.5M | Apr 2025 |
 MindImmune Therapeutics, Inc. | Series A | $30M | Jan 2025 |
 Vandria | Series A | — | Aug 2024 |
 Progentos Therapeutics | Series A | $65M | May 2024 |
 Cerevance | Series C | $51M | Apr 2024 |
 Esper | Pre-Seed | $1M | Mar 2024 |
 Leo Labs | Series B | $29M | Feb 2024 |
 Motif Neurotech | Unknown | $18.8M | Jan 2024 |
| Motif Neurotech | Series A | $18.8M | Jan 2024 |
 NeuroTherapia | Series B | $12.3M | Jan 2024 |
 Cognitive Space | Unknown | $4M | Oct 2023 |
 Paradromics | Series A | $33M | May 2023 |
 Mojo Vision | Series A | $22.4M | Apr 2023 |
 Qualis Corporation | Series B | $88M | Mar 2023 |
 Atomos Space | Series A | $16.2M | Jan 2023 |
 Atomos | Series A | $16.2M | Jan 2023 |
Page 1 of 4
Top Co-Investors
Khosla Ventures7 shared
Lux Capital7 shared
Dementia Discovery Fund7 shared
Gaingels7 shared
Pfizer Ventures7 shared
Mission BioCapital6 shared
Alsop Louie Partners6 shared
Johnson & Johnson Innovation5 shared
Y Combinator5 shared
Alexandria Venture Investments5 shared
GV4 shared
Sanofi Ventures4 shared
Amgen Ventures4 shared
INKEF Capital4 shared
Prime Movers Lab4 shared
AVG Basecamp4 shared
Wavemaker Three-Sixty Health4 shared
KCRise Fund4 shared
General Catalyst4 shared
Last updated: 7 October 2026